Niva Bupa Health Insurance IPO
Live Updates, GMP, Subscription Data, and Financial Details
IPO Overview
Listed
Dates
Nov 07 to Nov 11 2024
Price Band
₹70 - 74
Current GMP
₹78.14 (5.59%)
Subscription
1.90 times
IPO Details
| IPO Date | November 7, 2024 to November 11, 2024 |
| Listing Date | Thursday, November 14, 2024 |
| Face Value | ₹10 per share |
| Price Band | ₹70 to ₹74 per share |
| Lot Size | 200 Shares |
| Total Issue Size | 297,297,297 shares (aggregating up to ₹2,200.00 Cr) |
| Fresh Issue | 108,108,108 shares (aggregating up to ₹800.00 Cr) |
| Offer for Sale | 189,189,189 shares of ₹10 (aggregating up to ₹1,400.00 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
| Share holding pre issue | 1,700,122,985 |
| Share holding post issue | 1,808,231,093 |
IPO Date
November 7, 2024 to November 11, 2024
Listing Date
Thursday, November 14, 2024
Face Value
₹10 per share
Price Band
₹70 to ₹74 per share
Lot Size
200 Shares
Total Issue Size
297,297,297 shares (aggregating up to ₹2,200.00 Cr)
Fresh Issue
108,108,108 shares (aggregating up to ₹800.00 Cr)
Offer for Sale
189,189,189 shares of ₹10 (aggregating up to ₹1,400.00 Cr)
Issue Type
Book Built Issue IPO
Listing At
BSE, NSE
Share holding pre issue
1,700,122,985
Share holding post issue
1,808,231,093
IPO Subscription Details
| Anchor Investors | 1 |
| Qualified Institutions | 2.17 |
| Non-Institutional Buyers | 0.71 |
| bNII (bids above ₹10L) | 0.70 |
| sNII (bids below ₹10L) | 0.74 |
| Retail Investors | 2.88 |
| Total ** | 1.90 |
Anchor Investors
1
Qualified Institutions
2.17
Non-Institutional Buyers
0.71
bNII (bids above ₹10L)
0.70
sNII (bids below ₹10L)
0.74
Retail Investors
2.88
Total **
1.90
Day Wise Sub
| Day | QIB | NII | Retail | Total |
|---|---|---|---|---|
| Day 1 Nov 7, 2024 | 0.83 | 0.35 | 0.76 | 0.69 |
| Day 2 Nov 8, 2024 | 1.59 | 0.42 | 1.43 | 1.24 |
| Day 3 Nov 11, 2024 | 2.17 | 0.71 | 2.88 | 1.90 |
DayDay 1
Nov 7, 2024
QIB0.83
NII0.35
Retail0.76
Total0.69
DayDay 2
Nov 8, 2024
QIB1.59
NII0.42
Retail1.43
Total1.24
DayDay 3
Nov 11, 2024
QIB2.17
NII0.71
Retail2.88
Total1.90
Day Wise GMP
| Date | Price | GMP | Estimate List Price |
|---|---|---|---|
| 14-11-2024 | 74.00 | 1(1.35%) | 75 |
| 13-11-2024 | 74.00 | 1(1.35%) | 75 |
| 12-11-2024 | 74.00 | 0(0%) | 74 |
| 11-11-2024 | 74.00 | 0(0%) | 74 |
| 10-11-2024 | 74.00 | 3(4.05%) | 77 |
| 09-11-2024 | 74.00 | 3(4.05%) | 77 |
| 08-11-2024 | 74.00 | 0(0%) | 74 |
| 07-11-2024 | 74.00 | 0(0%) | 74 |
| 06-11-2024 | 74.00 | 0(0%) | 74 |
| 05-11-2024 | 74.00 | 0(0%) | 74 |
| 04-11-2024 | 74.00 | 0(0%) | 74 |
| 03-11-2024 | 0(0%) | (0%) | |
| 02-11-2024 | 0(0%) | (0%) | |
| 01-11-2024 | 0(0%) | (0%) | |
| 31-10-2024 | 0(0%) | (0%) |
Date14-11-2024
Price74.00
GMP1(1.35%)
Estimate List Price75
Date13-11-2024
Price74.00
GMP1(1.35%)
Estimate List Price75
Date12-11-2024
Price74.00
GMP0(0%)
Estimate List Price74
Date11-11-2024
Price74.00
GMP0(0%)
Estimate List Price74
Date10-11-2024
Price74.00
GMP3(4.05%)
Estimate List Price77
Date09-11-2024
Price74.00
GMP3(4.05%)
Estimate List Price77
Date08-11-2024
Price74.00
GMP0(0%)
Estimate List Price74
Date07-11-2024
Price74.00
GMP0(0%)
Estimate List Price74
Date06-11-2024
Price74.00
GMP0(0%)
Estimate List Price74
Date05-11-2024
Price74.00
GMP0(0%)
Estimate List Price74
Date04-11-2024
Price74.00
GMP0(0%)
Estimate List Price74
Date03-11-2024
Price
GMP0(0%)
Estimate List Price(0%)
Date02-11-2024
Price
GMP0(0%)
Estimate List Price(0%)
Date01-11-2024
Price
GMP0(0%)
Estimate List Price(0%)
Date31-10-2024
Price
GMP0(0%)
Estimate List Price(0%)
IPO Important Dates
| IPO Open Date | Thursday, November 7, 2024 |
| IPO Close Date | Monday, November 11, 2024 |
| Basis of Allotment | Tuesday, November 12, 2024 |
| Initiation of Refunds | Wednesday, November 13, 2024 |
| Credit of Shares to Demat | Wednesday, November 13, 2024 |
| Listing Date | Thursday, November 14, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on November 11, 2024 |
IPO Open Date
Thursday, November 7, 2024
IPO Close Date
Monday, November 11, 2024
Basis of Allotment
Tuesday, November 12, 2024
Initiation of Refunds
Wednesday, November 13, 2024
Credit of Shares to Demat
Wednesday, November 13, 2024
Listing Date
Thursday, November 14, 2024
Cut-off time for UPI mandate confirmation
5 PM on November 11, 2024
IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 200 | ₹14,800 |
| Retail (Max) | 13 | 2600 | ₹192,400 |
| S-HNI (Min) | 14 | 2,800 | ₹207,200 |
| S-HNI (Max) | 67 | 13,400 | ₹991,600 |
| B-HNI (Min) | 68 | 13,600 | ₹1,006,400 |
ApplicationRetail (Min)
Lots1
Shares200
Amount₹14,800
ApplicationRetail (Max)
Lots13
Shares2600
Amount₹192,400
ApplicationS-HNI (Min)
Lots14
Shares2,800
Amount₹207,200
ApplicationS-HNI (Max)
Lots67
Shares13,400
Amount₹991,600
ApplicationB-HNI (Min)
Lots68
Shares13,600
Amount₹1,006,400
Financial Information
| Period Ended | 30 Jun 2024 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Period Ended | 30 Jun 2024 | 31 Mar 2024 | 31 Mar 2023 |
| Assets | 6,542.06 | 6,191.87 | 3,876.57 |
| Revenue | 1,124.90 | 4,118.63 | 2,859.24 |
| Profit After Tax | -18.82 | 81.85 | 12.54 |
| Net Worth | 2,031.77 | 2,049.59 | 831.12 |
| Reserves and Surplus | 1,282.44 | 1,282.02 | 334.26 |
| Total Borrowing | 250.00 | 250.00 | 250.00 |
Period EndedPeriod Ended
30 Jun 202430 Jun 2024
31 Mar 202431 Mar 2024
31 Mar 202331 Mar 2023
Period EndedAssets
30 Jun 20246,542.06
31 Mar 20246,191.87
31 Mar 20233,876.57
Period EndedRevenue
30 Jun 20241,124.90
31 Mar 20244,118.63
31 Mar 20232,859.24
Period EndedProfit After Tax
30 Jun 2024-18.82
31 Mar 202481.85
31 Mar 202312.54
Period EndedNet Worth
30 Jun 20242,031.77
31 Mar 20242,049.59
31 Mar 2023831.12
Period EndedReserves and Surplus
30 Jun 20241,282.44
31 Mar 20241,282.02
31 Mar 2023334.26
Period EndedTotal Borrowing
30 Jun 2024250.00
31 Mar 2024250.00
31 Mar 2023250.00
Key Performance Indicator
| Debt/Equity | 0.12 |
| RoNW | -0.92 |
| P/BV | 6.14 |
| EPS (Rs) | 0.48 |
Debt/Equity
0.12
RoNW
-0.92
P/BV
6.14
EPS (Rs)
0.48
IPO Reservation
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | 13,37,83,783 (45%) | NA |
| QIB Shares Offered | 8,91,89,190 (30%) | NA |
| NII (HNI) Shares Offered | 4,45,94,595 (15%) | |
| bNII > ₹10L | 2,97,29,730 (10%) | 10,617 |
| sNII < ₹10L | 1,48,64,865 (5%) | 5,308 |
| Retail Shares Offered | 2,97,29,730 (10%) | 1,48,648 |
| Total Shares Offered | 29,72,97,298 (100%) |
Investor CategoryAnchor Investor Shares Offered
Shares Offered13,37,83,783 (45%)
Maximum AllotteesNA
Investor CategoryQIB Shares Offered
Shares Offered8,91,89,190 (30%)
Maximum AllotteesNA
Investor CategoryNII (HNI) Shares Offered
Shares Offered4,45,94,595 (15%)
Maximum Allottees
Investor CategorybNII > ₹10L
Shares Offered2,97,29,730 (10%)
Maximum Allottees10,617
Investor CategorysNII < ₹10L
Shares Offered1,48,64,865 (5%)
Maximum Allottees5,308
Investor CategoryRetail Shares Offered
Shares Offered2,97,29,730 (10%)
Maximum Allottees1,48,648
Investor CategoryTotal Shares Offered
Shares Offered29,72,97,298 (100%)
Maximum Allottees
Information about company
Incorporated in 2008, Niva Bupa Health Insurance Company Limited is a joint venture between the Bupa Group and Fettle Tone LLP that provides insurance in the health sector.
The company offers a holistic proposition by providing customers access to a comprehensive health ecosystem and service capabilities through its Niva Bupa Health mobile application and website.
The company's products are broadly categorized into
Retail products designed for individuals and families.
Group products intended for employers and employees,
As of March 31 2024, the company had 14.73 million active lives insured.
As of March 31, 2024, the company is present across 22 states and four union territories in India.
From Fiscal Year 2022 to Fiscal Year 2024, the overall GWP grew at a CAGR of 41.27%, while GWP from retail health increased by 33.41%.
As of March 31, 2024, the telemarketing sales team has 410 employees. It uses machine learning lead scoring, product recommendations, and a real-time CRM dashboard to engage customers and drive conversions.
Competitive Strength:
Diverse product range to suit customer's needs.
An automated approach to customer service driven by technology.
Bupa parentage and brand associated with health insurance and healthcare
The company's expertise and experience in claims and provider management.
As of March 31, 2024, the company's technology function had 126 employees who focused on developing digital assets, software, and mobile applications.
Objectives of IPO
The company proposes to utilise the Net Proceeds towards the following objects:
Augmentation of its capital base to strengthen solvency levels and
General corporate purposes
Disclaimer
All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application.
No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever
Please read all Tearms and conditions , and agree to use the App